Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Health Male Volunteers (MOLZ)

NCT01491503 Phase 1 COMPLETED

The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.

Details

Lead sponsor	Hanmi Pharmaceutical Company Limited
Phase	Phase 1
Status	COMPLETED
Enrolment	30
Start date	2011-11
Completion	2012-01

Conditions

• Healthy

Interventions

• Levocetirizine
• montelukast sodium
• Montelukast & levocetirizine

Primary outcomes

• AUClast — 0-36hrs
• Cmax — 0-36hrs

Countries

South Korea